Chonju, Korea, Republic of Clinical Trials

A listing of Chonju, Korea, Republic of clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
Study of Adjuvant ONO-4538 With Resected Gastric Cancer

The purpose of study is to evaluate the efficacy and safety of postoperative adjuvant chemotherapy with Nivolumab in combination with tegafur-gimeracil-oteracil potassium (S-1 therapy) or capecitabine + oxaliplatin (CapeOX therapy), in comparison with placebo in combination with S-1 therapy or CapeOX therapy, in pStage III gastric cancer (including esophagogastric junction …

oxaliplatin
lymphadenectomy
immunostimulants
gastric adenocarcinoma
capecitabine
Jeollabuk-do Clinical Site
 (7.3 away) Contact site
  • 174 views
  • 25 Jan, 2021
  • +106 other locations
The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque

The purpose of this study is to determine whether preventive coronary intervention on functionally insignificant coronary stenosis with vulnerable plaque characteristics plus optimal medical therapy reduces the incidence of the composite of cardiovascular death, target vessel myocardial infarction, or ischemia driven target lesion revascularization compared with optimal medical therapy alone.

myocardial infarction
luminal
ischemia
coronary artery stenosis
percutaneous coronary intervention
The Catholic University of Korea, Daejeon ST. Mary's Hospital
 (38.5 away) Contact site
  • 94 views
  • 28 Jan, 2021
  • +37 other locations
A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer

In oncological aspect, D1+ lymph node dissection would be enough for early stage gastric cancer in advanced gastric cancer (stage IB/IIA/IIB ).

metastasis
cancer
ct scan
gastrectomy
adenocarcinoma
Konyang University Hospital
 (38.5 away) Contact site
  • 12 views
  • 21 Jan, 2021
  • +46 other locations
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive HER2-Negative Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as first-line treatment) as measured by Progression Free Survival (PFS). This study will also evaluate efficacy, safety and tolerability of zolbetuximab, as well as its effects on quality …

Site KR82008
 (53.1 away) Contact site
  • 224 views
  • 02 Jun, 2021
  • +206 other locations
A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

A randomised phase III, double-blind, placebo-controlled trial with 2:1 (regorafenib : placebo)

Gyeongsang National University Hospital
 (69.7 away) Contact site
  • 98 views
  • 13 May, 2021
  • +52 other locations
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

This study [contRAst 2 (201791: NCT03970837)] is a phase 3, randomized, multicenter, double blind study to assess the safety and efficacy of GSK3196165 in combination with csDMARD(s), for the treatment of adult participants with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to csDMARD(s) or …

erosion
antirheumatics
chloroquine
rheumatic diseases
arthralgia
GSK Investigational Site
 (38.5 away) Contact site
  • 284 views
  • 14 May, 2021
  • +223 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

corticosteroids
antibiotics
severe chronic obstructive pulmonary disease
bronchodilator
eosinophil count
Research Site
 (81.2 away) Contact site
  • 832 views
  • 02 Jun, 2021
  • +422 other locations
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

This is a phase II study to evaluate the antitumor activity and safety of AFM13 given as monotherapy in patients with CD30-positive T-cell lymphoma. The investigational medicinal product AFM13 is a tetravalent bispecific chimeric (anti-human CD30 x anti-human CD16A) recombinant antibody construct which is being developed to treat CD30-positive malignancies. …

t-cell lymphoma
brentuximab
avid
systemic therapy
ct scan
Seoul National University Bundang Hospital
 (111.5 away) Contact site
  • 32 views
  • 30 Apr, 2021
  • +81 other locations
Tezepelumab COPD Exacerbation Study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

copd exacerbation
bronchodilator
ct scan
severe chronic obstructive pulmonary disease
Research Site
 (81.2 away) Contact site
  • 130 views
  • 16 May, 2021
  • +106 other locations
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma

This study is a phase I/II open-label study in patients with relapsed indolent NHL (Part A) or relapsed/refractory FL (Part B). Part A of the study assessed the safety and preliminary efficacy. This seamless design study now has four parts: 1) Part A, Ph I - dose escalation, 2) Part …

follicular lymphoma
platelet count
alkylating agent
antineoplastic
measurable disease
Samsung Medical Center
 (120.3 away) Contact site
  • 402 views
  • 11 Apr, 2021
  • +156 other locations